Increased Fracture Risk in Women Treated With Aromatase Inhibitors Versus Tamoxifen: Beneficial Effect of Bisphosphonates.
Increased Fracture Risk in Women Treated With Aromatase Inhibitors Versus Tamoxifen: Beneficial Effect of Bisphosphonates.
Increased Fracture Risk in Women Treated With Aromatase Inhibitors Versus Tamoxifen: Beneficial Effect of Bisphosphonates.
Analysis of bone impairment by 3D DXA hip measures in patients with primary hyperparathyroidism: a pilot study.
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.
In-vitro comparison of hydroxyapatite coatings obtained by cold spray and conventional thermal spray technologies
East-west gradient in hip fracture incidence in Spain:how much can we explain by following the pattern of risk factors?
Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis.
Fracture risk assessment in the general population in Spain by FRAX® algorithm. EPISER2016 study.
Atopic eczema and fracture risk in adults: A population-based cohort study.
Ten years change in post-fracture care for hip fracture patients.